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Abstract Our objective has been to establish a pro-
angiogenic role for exosomes in endometriosis and to deter-
mine whether a differential expression profile of cellular and
exosomal microRNAs (miRNAs) exists in endometriosis. We
performed an in vitro study of human primary endometrial
stromal cells (ESCs) and human umbilical vein endothelial
cells (HUVECs). We isolated and characterized exosomes
from ESCs from five endometriosis patients and five phase-
matched controls. Exosomes were characterized by transmis-
sion electron microscopy and NanoSight technology. MiRNA
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was assessed by deep sequencing and reverse transcription
with quantitative polymerase chain reaction. Exosome uptake
studies were achieved by means of confocal microscopy. The
pro-angiogenic experiments were executed by treating
HUVECs with ESC-derived exosomes. We observed differ-
ential profiles of exosomal miRNA expression between
exosomes derived from endometriosis lesion cells and dis-
eased eutopic stromal cells compared with exosomes derived
from control ESCs. We also demonstrated autocrine cellular
uptake of exosomes and paracrine functional angiogenic ef-
fects of exosomes on HUVECs. The results of this study sup-
port the hypothesis that exosomes derived from ESCs play
autocrine/paracrine roles in the development of endometriosis,
potentially modulating angiogenesis. The broader clinical im-
plications are that Sampson’s theory of retrograde menstrua-
tion possibly encompasses the finding that exosomes work as
intercellular communication modulators in endometriosis.
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Introduction
Endometriosis is a benign gynecological disorder character-
ized by the presence of endometrial glandular tissue and stro-
ma outside of their normal uterine location. Up to 10 % of
reproductive-age women in the United States are estimated to
have endometriosis, which is associated with debilitating pain,
menstrual irregularities, and infertility in as many 30 % of the
affected women (Bulun 2009; Verkauf 1987). The precise
etiology of endometriosis remains to be elucidated.
Commonly accepted theories of the causes of endometriosis
include retrograde menstruation, coelomic metaplasia, and
lymphatic and vascular dissemination (Macer and Taylor
2012). Patients with endometriosis often have delayed (6–
11 years) diagnosis because symptoms are variable and often
mimic other gynecological diseases (Fassbender et al. 2015;
Leone Roberti Maggiore et al. 2016; Nogales et al. 1993). A
definitive diagnosis of endometriosis requires surgery (Gordts
et al. 2015). The development of new ways of diagnosis by
using exosomal biomarkers might enable earlier diagnosis of
the disease (Fassbender et al. 2015).
Angiogenesis, the formation of new blood vessels, has in-
creasingly been recognized as a key pathological factor in endo-
metriosis. Human endometrial tissue is known to be angiogenic
throughout the menstrual cycle (Maas et al. 2001). Sampson’s
theory of retrograde menstruation posits that endometrial tissue
travels retrogradely through the Fallopian tubes and is deposited
into the peritoneal cavity, where it establishes a blood supply,
proliferates, and forms an implant that is clinically recognized as
a lesion (Sampson 1927).Womenwith endometriosis have been
found to have increased retrograde menstruation (Halme et al.
1984). Successful implantation of endometriotic lesions depends
on neovascularization, fibrosis, adhesion formation, apoptosis
evasion, and neuronal infiltration (Rocha et al. 2013). The exact
mechanisms underlying the sprouting and sustainment of endo-
metriosis neovascularization need further clarification. Recent
studies, however, demonstrate that inhibitors of angiogenesis
block the progression of endometriosis (Edwards et al. 2013;
Nap et al. 2004, Wang et al. 2014).
Exosomes have been found to play physiological roles as
mediators of intercellular cell signaling between neighboring
cells and even amongst distant tissues, and they may act inde-
pendently but synergistically with soluble growth factors and
hormones (Colombo et al. 2014). Exosomes are vesicles rang-
ing from 30 to 150 nm in diameter, are derived from the fusion
of multivesicular bodies with the plasma membrane, and are
secreted by a variety of living cells; they are composed of a
lipid bilayer membrane and contain functionally active pro-
teins, mRNA and microRNA (miRNA) that can be released,
rendering them important mediators of intercellular commu-
nication (Colombo et al. 2014). The recent discovery of these
extracellular organelles containing genetic cargo with a
unique signature raises the hope that exosomes will serve as
diagnostic markers or therapeutic vehicles (Krause et al. 2015;
Momen-Heravi et al. 2015; Tang and Wong 2015).
Among all molecules, the miRNAs that are contained with-
in exosomes (Valadi et al. 2007) could affect gene expression
and function in target cells, including vascular endothelial
cells. Several miRNAs, such as miR-21 and miR-126, have
been shown previously to play critical roles in angiogenesis
(Wang and Olson 2009). We have chosen to screen these two
miRNAs because, in previous literature, they have been wide-
ly used by the scientific community as pro-angiogenic indica-
tors in other systems (Bao et al. 2012; Guduric-Fuchs et al.
2012; Xu et al. 2015).
Additionally, endometrial exosomes released into the uter-
ine cavity can transfer information either to the blastocyst or to
other cells in the endometrium to influence implantation (Ng
et al. 2013). Our hypothesis is that exosomes released from
endometriotic stromal cells contribute to the pathogenesis of
endometriosis by packaging and delivering specific miRNAs
in an autocrine and paracrine fashion. In this study, we have
examined exosomes as delivery vehicles for pro-angiogenic
miRNA in endometriosis.
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Materials and methods
Human subjects and tissue acquisition
The study was approved by the institutional review boards of
the Emory University School of Medicine and Morehouse
School of Medicine. The primary endometrial stromal cells
(ESCs) were obtained from normally cycling, reproductive-
age women undergoing surgery for benign gynecological con-
ditions with normal endometrium (NE, n=5) and 5 women
with endometriosis who provided eutopic endometrial biop-
sies (EE, n=5) plus specimens from their endometriosis im-
plants (EI, n=5). For NE controls, endometrial tissues were
obtained from patients undergoing surgery for clinical indica-
tions, typically infertility, pelvic pain, or suspicion of a pelvic
mass, or some combination of findings under protocols ap-
proved by the Institutional Review Boards of the Emory
University School of Medicine and Morehouse School of
Medicine. All the subjects selected were women who had
regular menstrual cycles and who had not received hormonal
therapy for at least 3 months before surgery (Yu et al. 2014).
Absence of endometriosis in the NE group was confirmed
after surgical examination of the abdominal and pelvic cavity.
Specimens from controls were obtained from normally cy-
cling women undergoing surgery for benign gynecological
conditions in which no endometriosis or evidence of endome-
trial abnormalities was visible. Among the five control sub-
jects, subserosal fibroids were noted in four women, and none
were greater than 3 cm in diameter. Endometriosis patients
were identified at surgery by expert laparoscopists familiar
with the varied appearance of the lesions. Although the sub-
jects were not age-matched, their mean ages were not signif-
icantly different (Control, 40.4 ± 5.9; Endometriosis, 34.0
±7.8; P=0.53). The secretory menstrual phase according to
the day of the reproductive cycle was selected for all biopsies
to maximize consistency and was confirmed by histological
examination of the endometrial tissues. Written informed con-
sent was obtained prior to surgical removal of endometriotic
lesion tissue and endometrial biopsies.
Cell cultures and reagents
Primary ESCs were prepared from human tissue biopsies ac-
cording to our published procedure (Ryan et al. 1994). All
cultures (passages 3–5) were grown in complete medium to
70–90 % confluence in DMEM/Ham’s F-12 supplemented
with 10 % fetal bovine serum (FBS), 1 % non-essential amino
acids, 1 % sodium pyruvate, and 1 % penicillin streptomycin
and were incubated at 37 °C and 5 % CO2. Human umbilical
vein endothelial cells (HUVECs) were purchased from Lonza
(Walkersville, Md., USA) and were cultured in EBM-2 media
supplemented with EGM-2 MV cocktail (Lonza) together
with 1 % penicillin and streptomycin.
Isolation of exosomes
Once the desired confluence was obtained, the culture media
were removed, and ESCs were washed twice with 5 ml sterile
phosphate-buffered saline (PBS). The ESCs were then cul-
tured for an additional 48 h with growth media containing
exosome-depleted FBS. Exosome-depleted FBSwas obtained
by ultracentrifugation of FBS at 100,000g for 16 h at 4 °C.
The exosomal fraction from 5 ml culture media was isolated
by the Total Exosome Isolation kit (Invitrogen) according to
the manufacturer’s recommendations. First, the collected cell
culture media were centrifuged at 2000g for 30 min at room
temperature to remove cells and debris. Second, a half-volume
of the exosome isolation solution was added to cell-free cul-
ture media, and samples were refrigerated at 4 °C overnight.
The mixture was centrifuged at 10,000g for 1 h at 4 °C, and
the supernatant was removed by aspiration. The pellet was re-
suspended in 1× PBS and stored at −80 °C or directly proc-
essed for miRNA extraction (Li et al. 2015).
Identification of nanoparticles by nanoparticle tracking
analysis
Nanoparticle tracking analysis (NTA) measurements were
performed by using a NanoSight NS500 instrument
(NanoSight NTA 2.3 Nanoparticle Tracking and Analysis
Release Version Build 0025). The size distribution and quan-
tification of exosome preparations were analyzed by measur-
ing the rate of Brownian motion with a NanoSight LM10
system (NanoSight, Wiltshire, United Kingdom) equipped
with fast video capture and particle-tracking software.
Purified exosomes from NE, EE, and EI samples were diluted
in 500 μl of a solution of 1× PBS/5 mM EDTA and disaggre-
gated by using a syringe and needle (29-gauge). After this
procedure, the sample was injected into a NanoSight sample
cubicle. The mean±SD size distribution of ESC exosomes
was determined, and the mean number of particles per milli-
liter was compared between endometriosis patients (exosomes
derived from EE and EI ESCs) and exosomes derived from
eutopic NE cells of healthy subjects (Riches et al. 2014).
Exosome visualization by transmission electron
microscopy
Exosome suspension was loaded into a carbon-coated electron
microscopy grid. The sample was fixed with 2.5 % glutaral-
dehyde in 0.1 M cacodylate buffer for 2 h at 4 °C, followed by
a second fixation with 1 % osmium tetroxide in 0.1 M
cacodylate buffer for 1 h at 4 °C. After three washes in dis-
tilled H20, the sample was stained with 0.5 % aqueous uranyl
acetate for 2 h at room temperature. Transmission electron
microscopy samples were observed by using a JEOL
1200EX instrument.
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Exosome labeling
Exosomes were first obtained from non-labeled ESCs as
described above. The protein content of the exosomes
was adjusted to 1.4 μg/ml prior to labeling. Exosomal
membrane was labeled with BODIPY TR ceramide, ac-
cording to the manufacturer’s protocol (Molecular
Probes/Invitrogen Life Technologies). Briefly, exosome
pellets were re-suspended in 100 μl PBS and stained
with 10 μmol/L BODIPY TR ceramide with 594-
Alexa-Fluor (red) fluorescence. Excess fluorescent dye
was removed by using Exosome Spin Columns (Life
Technologies).
Confocal microscopy and imaging
Cells were cultivated on chamber slides, treated with a
final concentration of 28 ng/ml labeled exosomes (red)
for 20 min, fixed with 4 % paraformaldehyde at room
temperature for 20 min, permeabilized with ice-cold ac-
etone at room temperature for 5 min, and then stained
with fluorescent 488-Phalloidin (green) for actin using
the manufacturer’s recommendations (Molecular Probes/
Invitrogen Life Technologies). Fluorescence images
were collected on an inverted microscope (Zeiss LSM-
700) via a 40× objective. Zeiss acquisition parameters,
including exposure, focus, illumination, and Z stack
projection, were controlled by ZEN 2 software (Carl
Zeiss Microscopy). For the analysis of the cellular in-
t e rna l i za t ion of exosomes , images were a l so
deconvolved by using ZEN 2 software (Chu et al.
2012).
Endothelial tube formation assay
Sub-confluent HUVECs were harvested, resuspended in
medium, and treated with the indicated concentration of
exosomes or with PBS as a negative control. The exosome
protein concentration was measured by the Coomassie Plus
(CP) Protein Assay (Thermo Scientific). Treatment of cells
consisted of 50 μg total excreted exosomes extracted from
eutopic endometriosis and control endometrial cells. This
suspension was seeded (70,000 cells/well) in growth-
factor-reduced Geltrex Basement Membrane Matrix
(Gibco) on a 96-well plate (BD Bioscience) and incubated
up to 24 h at 37 °C with 5 % CO2. Tube formation was
examined under an inverted microscope and photographed
at 40× magnification. Cumulative tube length was mea-
sured by using ImageJ software (Schneider et al. 2012).
Results are shown as the mean and standard errors of trip-
licate experiments (Swift et al. 2010).
Micro-RNA extraction, deep sequencing, and reverse
transcription with quantitative polymerase chain reaction
Micro-RNA was extracted from exosomes and cells by
us ing the mirVana miRNA i s o l a t i on k i t (L i f e
Technologies) according to the manufacturer’s protocol.
RNA concentration and relative quality were determined
by using a Nanodrop Spectrophotometer (Thermo
Scientific). Samples were deemed acceptable if 260/280
ratios were greater than 1.6; 260/230 ratios were greater
than 1.0. miRNA (1 μg) was reverse-transcribed by using
the TaqMan MicroRNA Reverse Transcription Kit
(Applied Biosystems) following the manufacturer’s proto-
col. Primers for hsa-miR-21-5p (Cat. no. 4427975-
000397), hsa-miR-126-5p (Cat. no. 4427975-000451),
and U6 snRNA (Cat. no. 4427975-001973) were used
from miRNA kits (Applied Biosystems), and real-time
quantitative polymerase chain reaction (qPCR) was per-
formed by using the LC480 Lightcycler thermocycler
(Roche). snRNA U6 was used as an endogenous control
to normalize expression data. All samples were run in
triplicate, and the average value was used to calculate
the fold change values. The delta-delta of average Ct/Cp
value method was used to calculate the fold change values
among samples as previously described (Scarlett et al.
2014). Deep sequencing of total miRNAs was carried out
by SeqMatic LLC (Fremont, Calif., USA). Illumina se-
quencing libraries were generated by using the SeqMatic
TailorMix miRNA sample preparation kit. Sequencing was
performed by using the Illumina Genome Analyzer IIx
with a 1 × 36 bp single-end read. Data was de-
multiplexed by index barcode, and fastq files were gener-
ated by using Illumina pipeline (CASAVA). For data qual-
ity control, sequence reads were trimmed of the Illumina
adapters by using fastx clipper. Reads shorter than 15 bp
were removed from subsequent analyses. For data analy-
sis, clean sequence reads were mapped to the human ge-
nome (hg19) and to miRBase version 20 by using Bowtie.
Parameters were modified to allow for up to one mis-
match. Reads mapping to known miRNAs were counted.
Differential expression and P-value estimation were per-
formed by using DESeq for R statistical programming
language (Ge et al. 2014).
Statistics
Real-time qPCR results were expressed as means± standard
deviation (SD) from at least three separate experiments per-
formed in triplicate, unless otherwise stated. Differences be-
tween means among the treatment groups were analyzed by
using the Student two-tailed t-test or one-way analysis of var-
iance (ANOVA) with Holm-Sidak post-tests method where
appropriate. Quantitative analysis of branching length in the
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angiogenesis assay was performed with Pearson correlation
analysis. A P-value of <0.05 was considered significant.
SigmaPlot (version 11.0) and MS Excel software for
Windows were used for statistical analysis.
Results
Identification of ESC-derived exosomes in culture media
The ESC exosome purification procedure was validated by
using electron microscopy and NanoSight analysis.
Figure 1a shows an example of a transmission electron
micrograph of a representative exosome preparation. Further
characterization of exosomes, including size measurement
and quantification, from healthy (Fig. 1b–d, Supplementary
video 1) and endometriosis subjects was performed by using
NanoSight analysis, which demonstrated the purity of the
vesicles, with a peak size at 35 nm. This confirmed that the
ESCs of control and endometriosis subjects released exosomal
vesicles into their conditioned medium. No measurable
differences were observed in size or yield (Fig. 1e, f).
Autocrine internalization of exosomes by ESCs
We hypothesized that exosomes work in an autocrine/
paracrine fashion and can be internalized by nearby
cells to affect function in the uterine microenvironment
or peritoneal cavity. The internalization of labeled puri-
fied exosomes was visualized by confocal fluorescence
microscopy in ESCs (Fig. 2a–g, Supplementary Fig. S1,
Supplementary video 2). We observed that the internal-
ization of exosomes occurred within 2 min of exposure
to treatment, suggesting a fast uptake mechanism
(Fig. 2h, i). In these experiments (Fig. 2), we observed
the uptake of exogenous purified NE exosomes by NE
ESCs. Similar results were found when we used EE
exosomes on NE cells, and when we used EE cells.
The findings support the ability of exosomes to influ-
ence cell behavior via autocrine and/or paracrine routes.
Fig. 1 a Transmission electron microscopy of exosomes from control
endometrial stromal cells (ESCs). Bar 100 nm. b Scatter plot graph of
exosomes by using Nanosight technology shows that the majority of
exosomes are between 20 and 200 nm in size with a peak at 35 nm
(X = particle size, Z = count/ml). c Curve 1 describes the relationship
between particle number distribution (concentration/ml; left Y axis) and
particle size (in nm; X axis); curve 2 describes the correlation between the
cumulative percentage distribution of particles (percentile; right Y axis)
and particle size (X axis). d Still figure of exosome scatter nanoparticle
tracking in a NanoSight video (Supplementary video 1). e Repeated-
measure analysis of variance showing scatter plot column comparison
of means of exosome concentrations between the three groups (NE
normal endometrium, EE eutopic endometrium, EI endometriosis
implants). No measurable differences between the three groups were
observed (P = 0.655). f Scatter plot column comparison of means of
exosome sizes between the three groups. No measurable differences
between the three groups were observed (P= 0.529). Error bars are the
standard deviations of the different readings from different isolations
from T-75 flasks after 24 h of changing to exosome-free medium
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Pro-angiogenic effects of exosomes derived from ESCs
HUVECs plated on Geltrex Basement Membrane Matrix in
medium treated with exosomes extracted from eutopic endo-
metriosis ESC medium had greater tube formation compared
with those treated with exosomes extracted from control ESC
medium (Fig. 3a, b). A significant increase (P=0.033) of total
segment branch length was noted on HUVECs treated with
exosomes extracted from endometriosis cells compared with
control cells (Fig. 3c).
Differential expression of exosomal pro-angiogenic
miRNAs
Deep sequencing data also showed that several miRNAs
extracted from exosomes of NE and EE were differentially
expressed between the two groups (Fig. 3d). The deep se-
quencing results led to the identification of several miRNAs
that have yet to be characterized and confirmed in a larger
patient sample size. As angiogenesis has been recognized to
be a key pathological factor in endometriosis, we found,
from our deep sequencing heat-map data, that some
miRNAs could be predicted to be involved in the angiogen-
esis process. Since our endothelial tube assay showed pro-
angiogenic effects in EE-treated HUVECs, we analyzed
two known pro-angiogenic miRNAs (miR-21 and miR-
126) to determine whether differential expression occurred.
We investigated the expression in total miRNA extracted
from exosomes secreted by NE, EE, and EI ESCs.
Whereas the data did not reveal significant differences in
miR-126 among samples, EI cells showed an 11-fold in-
crease in miR-21 expression versus the healthy control
eu topic ESC exosomes (P < 0.0001; Fig . 3e , f ) .
Intracellular expression levels of miR-21 and miR-126 ex-
tracted from the producing cells in culture showed no sig-
nificant differences between groups (Fig. 3g, h).
Fig. 2 Uptake of exosomes by NE ESCs. The protein equivalent of
28 ng/ml labeled exosomes (red) was incubated for 20 min with ESCs,
which were then fixed in 4 % paraformaldehyde at room temperature for
20 min, subsequently permeabilized with ice-cold acetone at room
temperature for 5 min, and finally labeled with 488-Phalloidin (green).
Similar results were obtained when we used NE and EE exosomes, and
when we used EE cells. a ESCs labeled with 488-Phalloidin (green). b
Exosomes labeled with 594-Alexa-Fluor (red). c Merged image. a–c
Magnification: 40×. d–f Higher magnification of boxed areas in a–c. g
Z-stack slices running apical to basolateral in ESCs showing the ZX
(upper box) and ZY (right side box) cross sections of the selected cells
(Supplementary video 2) showing that the exosomes (red) are located
inside the ESCs and not on the top or bottom. h Uptake by the ESCs of
exosomes after 2 min of treatment. i Uptake by the ESCs of exosomes
after 8 min of treatment
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Discussion
Angiogenesis is necessary for the establishment and prolifer-
ation of endometriotic lesions (Shifren et al. 1996). Many
molecules and various mechanisms involved in lesion angio-
genesis are currently under study (Araldi et al. 2015; Kazanis
et al. 2015; Li et al. 2015).
We have demonstrated exosome release from ESCs and
confirmed the presence of exosomes by morphological anal-
ysis and dimensions. We have shown that the exosomes are
rapidly uptaken by ESCs in vitro (Fig. 2). No morphological
difference has been noted following the uptake of exosomes
from NE cells and from EE cells by either cell type. We pos-
tulate that specific surface ligands allow the highly efficient
and targeted uptake of these vesicles by recipient cells, as has
been shown in other cell types (Schneider and Simons 2013).
We hypothesize that ESC-released exosomes are taken up by
and have a pro-angiogenic effect on endothelial cells that
helps to promote tube formation. We have further shown dif-
ferential exosomal angiogenic activity on HUVECs in the in
vitro Matrigel assay. Endothelial cells are integrally necessary
for the formation of new blood vessels. We have observed
increased branching when the HUVECs are treated with EE
exosomes compared with NE exosomes (Fig. 3a–c). These
data suggest that exosomes play a role in promoting endothe-
lial cell formation and angiogenesis in endometriosis.
Exosomes from a variety of other cell types have been shown
to exert a pro-angiogenic effect on endothelial cells and on
stromal cells (Mineo et al. 2012; Paggetti et al. 2015; Pascucci
et al. 2014). From our data, we propose that exosomes can
play an important mediator role in the angiogenesis process in
vitro in a paracrine fashion.
In the present study, we show that ESCs release biological-
ly functional exosomes that can facilitate angiogenesis in a
validated in vitro assay. Exosomes carry a variety of bioactive
molecules: RNAs, DNAs, proteins, and lipids (Colombo et al.
2014). The various types of response in target cells induced by
exosomes derived from parent cells are probably determined
by their miRNA content (Pascucci et al. 2014; Shabbir et al.
2015). Our deep sequencing data suggest that endometriosis
Fig. 3 a HUVECs treated with exosomes extracted from control cells at
24 h. b HUVECs treated with exosomes extracted from endometriosis
patient cells at 24 h. c Significant increase of total segment branch length
is noted on HUVECs treated with exosomes extracted from EE cells
compared to those from NE cells (error bar SD). d Heat-map from
deep-sequencing depicting the most significant differential expression
of miRNAs extracted from exosomes of NE and from EE. e, f miR-21
and miR-126 expression, respectively, revealed by reverse transcription
and quantitative polymerase chain reaction (RT-qPCR) of RNA extracted
from exosomes from NE, EE, and EI samples. EI cells showed an 11-fold
increase in miR-21 expression versus the healthy control eutopic ESC
exosomes (P< 0.0001). No significant difference in miR-126 expression
was found among samples. g, h miR-21 and miR-126 expression,
respectively, revealed by RT-qPCR of RNA extracted from cells of NE,
EE, and EI samples. No significant differences between groups were
shown between intracellular expression levels of miR-21 and miR-126
extracted from the producing cells in culture
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patients have a differential expression of exosomal miRNA
patterns compared with controls (Fig. 3d). This signifies that
differential pathogenic roles and altered mechanisms are in-
volved in exosomal intercellular communication in the perito-
neal and intrauterine milieu.
Our results indicate that at least one of these factors, name-
ly the pro-angiogenic miRNA, miR-21, is differentially
expressed in lesion exosomes of endometriosis-derived sam-
ples (EI) relative to normal (NE) exosomes. Transferred
exosomal miRNA can reprogram the recipient cells. The link-
age between exosomal miRNAs and their effects in the recip-
ient cells remains to be fully elucidated. However, evidence to
date indicates that exosomes are powerful mediators of
intercellular communication (Tang and Wong 2015). We pro-
pose that the exposure of endothelial cells to ESC exosomes
leads to angiogenesis, with some of the effects possibly being
attributable to the overexpression of miR-21. Exosomes con-
tainingmiR-21 have been previously reported to stimulate cell
angiogenesis in other systems (Bao et al. 2012; Guduric-
Fuchs et al. 2012; Xu et al. 2015). We speculate that
exosome-derivedmiRNAs are potential angiogenic targets that
are relevant to endometriosis sequelae such as abnormal im-
plantation and infertility. Thus, these exosome-specific
miRNAs would be present in the uterine and peritoneal micro-
environments mediating cross-talk essential for the constella-
tion of secondary effects of endometriosis. The work
Fig. 4 Suggested model
depicting exosome shedding in
the endometrial cavity working in
an autocrine, paracrine, and
endocrine manner. Exosomes
may also be shed in a retrograde
fashion with menstrual flow and
be taken up by cells within the
peritoneal cavity or shed by
stromal cells in the menstrual
flow
194 Cell Tissue Res (2016) 365:187–196
presented here sets the basis for a path toward the discovery of
novel effective biomarkers for early diagnostics and potential
new drug targets.
This study supports the hypothesis that exosomes derived
from endometriotic stromal cells play autocrine/paracrine
roles in the endometrial and peritoneal microenvironments,
modulating angiogenesis. Figure 4 shows our suggested mod-
el of action of exosomes in the uterine microenvironment.
Additionally, exosomes can migrate further into other tissues
through blood vessels (endocrine; De Toro et al. 2015; Ng
et al. 2013; Salomon et al. 2014; Simpson et al. 2008) and
be transported to the peritoneal cavity through a retrograde
flow deposition system. Furthermore, these lesion exosomes
might modify angiogenesis in the local peritoneal
environment.
The broader clinical implications discussed are built on
Sampson’s theory of retrograde menstruation, a theory that
supports the idea that exosomes work as intercellular commu-
nication modulators in endometriosis. We suggest a model in
which exosomes secreted from diseased endometrial cells
stimulate the pro-angiogenic propensity of nascent lesions in
the peritoneum to adopt a new vasculature and cause inflam-
matory changes that lead to pelvic pain and infertility. This
pathogenic intercellular transfer of genetic material mediated
by exosome carriers could pave the road to new diagnostic
and therapeutic tools in the field of reproductive biology.
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